Syndax Pharmaceuticals rating affirmed By: MarketMinute.com Stock News March 14, 2018 at 17:48 PM EDT Morgan Stanley affirmed its Overweight rating on Syndax Pharmaceuticals Inc. (Nasdaq: SNDX) sending the stock price soaring $3.00 to close at $13.58. Related Stocks: Syndax Pharma